Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C

Authors:

Abstract
Murine SCC‐VII squamous carcinoma cells have the capacity to penetrate reconstituted basement membranes (Matrigel) in vitro. The invasion of Matrigel layers by SCC‐VII cells was significantly reduced by E‐64, a specific inhibitor of lysosomal cysteine proteinases. The cathepsin‐B‐selective E‐64 derivative, CA‐074, inhibited penetration of Matrigel by SCC‐VII cells to the same extent, indicating a major role for this particular lysosomal enzyme in extracellular‐matrix degradation during squamous‐carcinoma‐cell invasion. SCC‐VII cells were stably transfected with a cDNA encoding human procathepsin B, in an attempt to modulate the invasive properties of the cell line. The transfected cells expressed the heterologous gene, secreted increased amounts of procathepsin B and displayed enhanced invasive potential. In vivo, the activity of cathepsin B is strictly regulated by endogenous inhibitors. SCC‐VII cells were therefore also stably transfected with a cDNA encoding human cystatin C, the most potent cysteine‐proteinase inhibitor in mammalian tissues. The expression of this transgene resulted in the production of active recombinant cystatin C and a pronounced reduction in Matrigel invasion. These studies demonstrate that the invasive properties of squamous‐cell carcinomas can be changed by modulation of the balance between cathepsin B and its endogenous inhibitors, and provide further evidence for the involvement of this lysosomal cysteine proteinase in tumour invasion and metastasis. Int. J. Cancer. 83:526–531, 1999.

This publication has 18 references indexed in Scilit: